Jacobs Levy Equity Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q3
Sell
-88,400
Closed -$381K 940
2014
Q2
$381K Sell
88,400
-50,600
-36% -$218K 0.01% 678
2014
Q1
$569K Buy
+139,000
New +$569K 0.01% 650
2013
Q4
Sell
-48,100
Closed -$241K 1068
2013
Q3
$241K Sell
48,100
-43,000
-47% -$215K ﹤0.01% 834
2013
Q2
$406K Buy
+91,100
New +$406K 0.01% 765